沙门氏菌测试市场 - 全球产业规模、份额、趋势、机会和预测，按测试方法、样本类型、最终用户、地区和竞争细分，2019-2029F

2023 年全球沙门氏菌检测市场价值为 24.5 亿美元，预计在预测期内将稳定成长，到 2029 年复合年增长率为 5.62%。呕吐涉及检测食物、水或生物样本等各种样品中的细菌。该过程通常采用特定的实验室条件和基于培养的方法来分离沙门氏菌，随后透过生化测试和有时的血清分型进行确认。在分子研究中，聚合酶链反应 (PCR) 经常用于快速、准确地检测沙门氏菌 DNA 或 RNA。此外，免疫测定对于快速检测沙门氏菌抗原或抗体很有价值，可以作为有效的筛检工具。此类检测在确保食品安全、诊断人类和动物疾病以及调查疫情爆发方面发挥着至关重要的作用。根据食品安全或临床诊断的特定目的，选择不同的方法。例如，临床实验室对疑似食物中毒的患者进行筛检，诊断沙门氏菌感染。

市场概况
预测期	2025-2029
2023 年市场规模	24.5亿美元
2029 年市场规模	33.6亿美元
2024-2029 年复合年增长率	5.62%
成长最快的细分市场	基于分子的方法
最大的市场	北美洲

FDA 和 EFSA 等机构的严格法规推动了稳健测试协议的采用。自动化可以减少大规模测试中的错误并提高效率。快速诊断测试可为及时介入提供快速结果，儘管它们最初可能成本高昂，限制了某些行业的采用。由于技术进步、食品安全意识不断提高以及全球法规更加严格，沙门氏菌检测市场不断成长。未来的工作重点是开发更快、更灵敏和更具成本效益的方法来改善沙门氏菌检测和预防。

主要市场驱动因素

食源性疾病的发生率不断增加

严格的监管框架

主要市场挑战

样本复杂度

新兴菌株

主要市场趋势

专注于联合疗法

细分市场洞察

测试方法见解

样本类型见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球沙门氏菌检测市场的影响

第 5 章：全球沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法（基于培养的方法、基于分子的方法和免疫测定）
  • 依样品类型（食物、水和环境表面）
  • 按最终用户（食品生产商和製造商、合约测试实验室、政府和监管机构等）
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 6 章：亚太地区沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法
  • 依样品类型
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 7 章：欧洲沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法
  • 依样品类型
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 8 章：北美沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法
  • 依样品类型
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 9 章：南美沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法
  • 依样品类型
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲沙门氏菌检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试方法
  • 依样品类型
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋沙门氏菌检测市场展望
    • 市场规模及预测
      • 按价值
    • 市占率及预测
      • 按测试方法
      • 依样品类型
      • 按最终用户

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 13 章：全球沙门氏菌检测市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Merck KGaA
• QIAGEN NV
• Eurofins Scientific
• Hardy Diagnostics
• PerkinElmer AES
• Mylab Discovery Solutions Pvt. Ltd.
• Abbott Laboratories Inc.
• Biomerica, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Salmonella Testing Market was valued at USD 2.45 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.62% through 2029. Testing for Salmonella, a common cause of foodborne illnesses characterized by symptoms such as diarrhea, fever, cramps, and vomiting, involves detecting the bacteria in various samples like food, water, or biological specimens. This process typically employs specific laboratory conditions and culture-based methods to isolate Salmonella, which is subsequently confirmed through biochemical tests and sometimes serotyping. In molecular studies, Polymerase Chain Reaction (PCR) is frequently utilized to swiftly and accurately detect Salmonella DNA or RNA. Additionally, immunoassays are valuable for rapidly detecting Salmonella antigens or antibodies, serving as effective screening tools. Such testing plays a critical role in ensuring food safety, diagnosing illnesses in both humans and animals, and investigating outbreaks. Depending on the specific purpose whether it's food safety or clinical diagnosis different methodologies are chosen. Clinical laboratories, for instance, conduct screenings to diagnose Salmonella infections in patients suspected of food poisoning.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 2.45 Billion
Market Size 2029	USD 3.36 Billion
CAGR 2024-2029	5.62%
Fastest Growing Segment	Molecular-Based Methods
Largest Market	North America

Stringent regulations from agencies like the FDA and EFSA drive adoption of robust testing protocols. Automation reduces errors and boosts efficiency in large-scale testing. Rapid diagnostic tests offer quick results for prompt interventions, although they can be costly initially, limiting adoption in some sectors. The Salmonella testing market grows due to technological advancements, rising awareness of food safety, and stricter global regulations. Future efforts focus on developing faster, more sensitive, and cost-efficient methods to improve Salmonella detection and prevention.

Key Market Drivers

Increasing Incidences of Foodborne Illness

As instances of foodborne illnesses increase, there is a growing need for dependable and efficient solutions for testing Salmonella. This includes rapid diagnostic tests for swift identification during outbreaks and thorough testing methods for ongoing surveillance in food production. According to the World Health Organization (WHO), unsafe food results in 600 million cases of foodborne diseases and 420,000 deaths annually worldwide. This concern compels governments, regulatory bodies, and food producers to enforce rigorous testing protocols to ensure food safety and prevent outbreaks.

Heightened consumer awareness about food safety issues has raised expectations for the safety and quality of food products. This prompts food producers to invest in robust Salmonella testing to uphold consumer confidence and comply with regulatory standards. According to a report by the World Bank, unsafe food results in an annual loss of US$ 110 billion in productivity and medical expenses in low- and middle-income countries. Globally, one in ten people falls ill after consuming contaminated food. The globalization of food supply chains has increased the risk of contamination and transmission of pathogens such as Salmonella across borders. Consequently, maintaining international trade and consumer safety necessitates consistent and dependable testing practices.

The escalating occurrences of foodborne illnesses attributed to Salmonella are driving substantial demand for advanced and reliable testing solutions in the Salmonella testing market. This trend is anticipated to continue shaping the market landscape, fostering the development of new technologies and stringent testing protocols to bolster global food safety standards.

Stringent regulatory frameworks

Government regulations mandate testing for Salmonella and other pathogens in food products to ensure consumer safety. These regulations define the types of tests, frequency of testing, and acceptable pathogen limits, thereby increasing the demand for testing services and products. The USDA's FSIS plans to introduce a formal regulatory proposal for Salmonella in poultry by 2024. Similarly, the CFIA has updated its Salmonella Testing Regulations for Hatcheries and Poultry Breeders to align with US and EU standards, aiming to prevent and control foodborne illnesses linked to poultry and eggs, and to achieve national consistency, modernization, and alignment with global trading partners.

Regulatory bodies such as the FDA in the US and EFSA in Europe enforce rigorous standards to prevent Salmonella-related foodborne illnesses. Compliance with these standards is crucial for food producers to avoid penalties and maintain their market credibility. The European Union's Commission Regulation (EC) No 2073/2005 establishes microbiological criteria for food safety, including Salmonella, to be applied from January 1, 2006, for various foodborne bacteria and toxins.

There is an increasing trend towards global harmonization of food safety regulations to facilitate international trade. This shift compels manufacturers to adopt standardized testing methods that meet regulatory requirements across different regions. Regulatory compliance plays a pivotal role in enhancing consumer confidence in food products. Consumers expect manufacturers to adhere to stringent testing standards set by regulatory authorities to protect their health and well-being. Stringent regulatory frameworks generate consistent demand for Salmonella testing services from food producers, testing laboratories, and regulatory agencies themselves. This demand expansion contributes to the growth of the testing solutions market.

Key Market Challenges

Sample Complexity

Sample complexity presents a significant hurdle for the Salmonella testing market because Salmonella can be detected in a wide range of sources. It appears in various types of samples such as food products (like meat, dairy, and eggs), environmental samples (including water and soil), and clinical samples (such as feces and blood). Each type of sample necessitates different preparation and enrichment methods to effectively detect the pathogen. Food matrices and environmental samples often contain substances that can disrupt testing methods, potentially resulting in incorrect test outcomes. For instance, fats, proteins, and other compounds found in food matrices might impede bacterial growth or interfere with molecular detection techniques. In addition, environmental samples can harbor intricate microbial communities, which might obscure the identification of Salmonella or introduce competition during enrichment processes. Distinguishing Salmonella from closely related species or background microflora further complicates the testing process. Furthermore, validating Salmonella testing techniques across diverse sample types poses challenges due to variations in matrix composition, bacterial concentration, and possible sources of interference. Methods that have been validated for one type of sample may not perform equally well with others. Regulatory bodies typically impose specific criteria for Salmonella testing in different sample types such as food, water, and clinical specimens. Complying with these requirements while maintaining consistent and accurate results adds another layer of complexity to the process.

Emerging Strains

The emergence of novel Salmonella strains presents a significant market challenge for the Salmonella testing industry. These new strains often contain genetic variations that may not be effectively identified using current testing methodologies, thereby compromising the reliability and efficacy of existing protocols. For instance, Salmonella Typhi strains frequently exhibit resistance to ciprofloxacin, reducing treatment options. In a recent study conducted at the Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata (IZSPB) laboratories, six Salmonella Infantis strains were isolated from broiler litter and carcasses between 2018 and 2022. The investigation, published in the Microorganisms journal, evaluated their phenotype, antibiotic resistance, and genomic profiles. Emerging strains may harbor distinct virulence factors or antibiotic resistance profiles, potentially leading to more severe infections or treatment challenges. This underscores the critical need for accurate and timely detection to prevent outbreaks and mitigate health risks. Given the global nature of food supply chains, Salmonella strains can rapidly spread across regions. This underscores the importance of standardized testing protocols and international cooperation to effectively monitor and manage the dissemination of new strains. Addressing these challenges necessitates collaboration among industry stakeholders, regulatory bodies, and research institutions to develop and deploy effective strategies for detecting and responding to emerging Salmonella strains.

Key Market Trends

Focus on Combination Therapies

Technological advancements are pivotal in shaping the Salmonella testing market, fostering innovation and enhancing capabilities across various sectors. Polymerase Chain Reaction (PCR) and other molecular diagnostic methods have revolutionized Salmonella testing, providing rapid, sensitive, and specific detection of bacteria. These techniques are essential for precise detection of low levels of Salmonella in diverse sample types, crucial for clinical diagnostics and food safety. The market for rapid diagnostic tests (RDTs) is expanding, offering quick on-site detection of Salmonella through immunological methods like lateral flow assays or antigen-antibody interactions, delivering results within minutes. In 2024, a novel technology utilizing magnetic nanoparticles (MNPs) and gold nanoparticles (GNPs) was introduced to improve Salmonella detection in poultry. MNPs concentrate bacterial cells using magnets from large-volume samples, while GNPs are tailored to selectively react with Salmonella-specific DNA. Another innovation in 2023 involved CrisprBits, leveraging CRISPR gene-editing technology to develop a point-of-care testing platform for multiple pathogens, including Salmonella. These tests are undergoing validation studies and anticipate market entry following approvals from regulatory bodies like the Central Drugs Standard Control Organisation (CDSCO).

AI and data analytics are further enhancing Salmonella testing by enabling advanced data processing, pattern recognition, and predictive modeling. Ancera, in 2023, launched the Ancera Salmonella System Monitoring (SSM) software platform. This system integrates mobile surveillance networks, CRISPR databases, epidemiological models, and predictive software to provide real-time insights into Salmonella across the poultry supply chain, thereby mitigating risks and improving operational efficiency.These advancements underscore ongoing efforts in research and development, poised to drive innovation, enhance accuracy, and expand applications of Salmonella testing globally. Continued progress in these areas is expected to fuel the evolution and growth of the Salmonella testing market in the years ahead. enhanced

Segmental Insights

Testing Method Insights

Based on Testing Method, the Molecular-based Methods emerged as the fastest growing segment in the global market for Salmonella Testing during the forecast period. Molecular-based methods, such as Polymerase Chain Reaction (PCR) and other nucleic acid amplification techniques, enable rapid detection of Salmonella DNA or RNA. They deliver results in a matter of hours, contrasting with the days typically required by conventional culture-based methods. Ongoing advancements in molecular diagnostics, including real-time PCR and next-generation sequencing (NGS), continually enhance the speed, sensitivity, and capacity for multiplexing, driving their widespread adoption. In 2023, researchers from the Singapore Food Agency's National Center for Food Science and the National University of Singapore developed a real-time PCR approach for detecting viable Salmonella Enteritidis contamination in shell eggs. Integration of this method could significantly expedite traditional Salmonella testing processes. Automation and high-throughput technologies have further bolstered the appeal of molecular methods by enabling the simultaneous processing of large sample volumes. This capability makes molecular methods suitable for both routine testing and rapid response during outbreak investigations. Molecular-based methods have garnered broad regulatory acceptance for Salmonella testing across diverse industries and geographic regions. These methods can be seamlessly integrated with other technologies such as real-time PCR, multiplex PCR, and NGS, allowing for concurrent detection of multiple pathogens and genetic variants. This integrative capacity supports comprehensive pathogen surveillance and facilitates epidemiological studies. The combination of speed, sensitivity, regulatory endorsement, and integration with advanced technologies positions molecular-based methods as indispensable tools for ensuring food safety, diagnosing infections, and upholding global public health standards.

Sample Type Insights

Based on Sample Type, Food emerged as the dominating segment in the global market for Salmonella Testing in 2023. Food items, especially raw meats, poultry, eggs, dairy products, and fresh produce are common carriers of Salmonella, with contamination possible at multiple stages from production through to distribution and preparation. Salmonella presence in food can result in widespread foodborne illnesses, posing substantial risks to public health. In 2024, New Zealand Food Safety issued a recall of Davis Trading Company's imported sesame seeds due to potential Salmonella contamination. Ensuring the safety and quality of food products is essential for maintaining consumer confidence. Regular testing for pathogens like Salmonella allows food manufacturers to demonstrate their commitment to food safety and compliance with industry regulations. Advancements in molecular-based testing methods, such as PCR and NGS, have significantly enhanced the speed, accuracy, and sensitivity of Salmonella detection in food samples. These technologies facilitate quicker turnaround times for test results, crucial for timely responses to prevent contamination spread.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Salmonella Testing Market in 2023. In North America, there is a significant incidence of foodborne illnesses attributed to Salmonella contamination. This heightened prevalence underscores the demand for effective testing methods aimed at detecting and preventing outbreaks, thereby safeguarding public health. Recent data from the Centers for Disease Control and Prevention reveal that approximately 48 million people in the U.S. fall ill, with 128,000 hospitalized and 3,000 fatalities annually due to foodborne diseases. The United States, specifically, maintains stringent regulatory oversight through bodies such as the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA). These agencies enforce rigorous food safety regulations that necessitate routine testing for Salmonella and other pathogens in food products to ensure consumer safety. North America benefits from advanced healthcare infrastructure and robust diagnostic capabilities. State-of-the-art laboratories equipped with molecular-based testing technologies like PCR and NGS enable rapid and precise detection of Salmonella. Consumer awareness of food safety issues is high in North America, driving a strong preference for safe and high-quality food products. This consumer demand incentivizes food producers to invest in stringent testing protocols and innovative technologies to uphold consumer trust. In 2023, scientists at the U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) developed a new method using Loop-mediated isothermal amplification (LAMP) for Salmonella testing in animal food. This advancement underscores the critical importance of product testing to ensure the safety of consumers, pets, and other animals from foodborne infections.Ongoing advancements in molecular testing methods, automation, and data analysis continually improve the efficiency, sensitivity, and throughput of Salmonella testing processes in North America, further enhancing food safety standards and public health protection.

Key Market Players

Thermo Fisher Scientific Inc.

BioMerieux SA

Merck KGaA

QIAGEN N.V.

Eurofins Scientific

Hardy Diagnostics

PerkinElmer AES

Mylab Discovery Solutions Pvt. Ltd.

Abbott Laboratories Inc.

Biomerica, Inc.

Report Scope:

In this report, the Global Salmonella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Salmonella Testing Market, By Testing Method:

Culture-based Methods Molecular-based Methods Immunoassays

Salmonella Testing Market, By Sample Type:

Food Water Environmental Surfaces

* Salmonella Testing Market, By End User:

Food Producers and Manufacturers Contract Testing Laboratories Government and Regulatory Bodies Others

Salmonella Testing Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Salmonella Testing Market.

Available Customizations:

Global Salmonella Testing Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Salmonella Testing Market

5. Global Salmonella Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays)
  • 5.2.2. By Sample Type (Food, Water, and Environmental Surfaces)
  • 5.2.3. By End User (Food Producers and Manufacturers, Contract Testing Laboratories, and Government and Regulatory Bodies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map

6. Asia Pacific Salmonella Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing Method
  • 6.2.2. By Sample Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Salmonella Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing Method
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By End User
  • 6.3.2. India Salmonella Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing Method
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Salmonella Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing Method
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Salmonella Testing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Testing Method
      • 6.3.4.2.2. By Sample Type
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Salmonella Testing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Testing Method
      • 6.3.5.2.2. By Sample Type
      • 6.3.5.2.3. By End User

7. Europe Salmonella Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing Method
  • 7.2.2. By Sample Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Salmonella Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing Method
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Salmonella Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing Method
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Salmonella Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing Method
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Salmonella Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing Method
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Salmonella Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing Method
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By End User

8. North America Salmonella Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing Method
  • 8.2.2. By Sample Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Salmonella Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing Method
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Salmonella Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing Method
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Salmonella Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing Method
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By End User

9. South America Salmonella Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing Method
  • 9.2.2. By Sample Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Salmonella Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing Method
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Salmonella Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing Method
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Salmonella Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing Method
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Salmonella Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing Method
  • 10.2.2. By Sample Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Salmonella Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing Method
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Salmonella Testing Market Outlook
    • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing Method
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Salmonella Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing Method
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Salmonella Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
• 15.2. BioMerieux SA
• 15.3. Merck KGaA
• 15.4. QIAGEN N.V.
• 15.5. Eurofins Scientific
• 15.6. Hardy Diagnostics
• 15.7. PerkinElmer AES
• 15.8. Mylab Discovery Solutions Pvt. Ltd.
• 15.9. Abbott Laboratories Inc.
• 15.10. Biomerica, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer